TABLE 1.
E. faecium isolate (n = 24) | MIC (μg/ml) of:
|
Synergy testing
|
|||||
---|---|---|---|---|---|---|---|
DAP by:
|
RIF by:
|
Etestb
|
TKA log10 changea | ||||
Etestb | BMD | Etestb | BMD | ΣFICs | Mean ΣFIC | ||
1 | 4 | 2 | 0.008 | 0.032 | 0.3, 0.5, 0.8 | 0.6 | −2.0 (SYN) |
2 | 4 | 1 | 16 | 8 | 0.1, 0.1, 0.1 | 0.1 | −2.0 (SYN) |
3 | 2 | 2 | 0.032 | 0.064 | 0.9, 0.9, 0.9 | 0.9 | −2.0 (SYN) |
4 | 2 | 2 | 0.016 | 0.064 | 0.2, 0.2, 0.3 | 0.2 | −4.0 (SYN) |
5 | 2 | 2 | 0.016 | ≤0.016 | 0.3, 0.2, 0.2 | 0.2 | −5.0 (SYN) |
6 | 1 | 2 | 16 | 16 | 0.2, 0.3, 0.2 | 0.2 | −2.4 (SYN) |
7 | 2 | 2 | 16 | 8 | 0.3, 0.3, 0.3 | 0.3 | −2.0 (SYN) |
8 | 2 | 2 | 0.016 | 0.032 | 0.3, 0.3, 0.2 | 0.3 | −2.1 (SYN) |
9 | 2 | 2 | >256 | >32 | 0.4, 0.4, 0.3 | 0.4 | −2.0 (SYN) |
10 | 2 | 1 | 8 | 1 | 0.2, 0.3, 0.4 | 0.3 | −2.0 (SYN) |
11 | 2 | 2 | 32 | 8 | 0.2, 0.2, 0.3 | 0.2 | −2.0 (SYN) |
12 | 2 | 4 | 32 | 16 | 0.2, 0.4, 1.0 | 0.5 | −2.6 (SYN) |
13 | 4 | 4 | 32 | 8 | 0.1, 0.4, 0.2 | 0.2 | −2.0 (SYN) |
14 | 2 | 2 | 0.016 | 0.032 | 0.4, 0.3, 0.4 | 0.4 | −2.5 (SYN) |
15 | 1 | 1 | 16 | 4 | 0.4, 0.4, 0.3 | 0.4 | −2.2 (SYN) |
16 | 2 | 0.5 | 16 | 4 | 0.3, 0.2, 0.2 | 0.2 | −2.0 (SYN) |
17 | 4 | 2 | 32 | 16 | 0.2, 0.2, 0.2 | 0.2 | −2.0 (SYN) |
18 | 4 | 1 | 0.032 | 0.032 | 1.0, 1.0, 1.0 | 1.0 | −2.0 (SYN) |
19 | 2 | 1 | 32 | 4 | 0.2, 0.2, 0.1 | 0.2 | −1.4 (IND) |
20 | 4 | 2 | 0.016 | ≤0.016 | 0.4, 0.3, 0.5 | 0.4 | −0.9 (IND) |
21 | 2 | 2 | 16 | 4 | 0.1, 0.2, 0.2 | 0.2 | −1.4 (IND) |
22 | 2 | 1 | 8 | 4 | 0.4, 0.4, 0.3 | 0.4 | −0.6 (IND) |
23 | 2 | 1 | 32 | 8 | 0.3, 0.3, 0.3 | 0.3 | −1.0 (IND) |
24 | 4 | 2 | 8 | 4 | 0.2, 0.2, 0.3 | 0.2 | −0.5 (IND) |
Values represent the log10 change (CFU/ml) in the TKA after 24-h exposure to DAP and RIF when compared to the most active drug alone. Negative values indicate a decrease in colony count. SYN, synergy; IND, indifference.
Performed in triplicate.